Steven Bartz

Company: Pfizer

Job title: Head of Oncology Business Development, Search & Evaluation

Bio:

Steven Bartz is Oncology S&E Team Lead at Pfizer.  The Pfizer Oncology S&E teams looks for opportunities to transact with companies that enable Pfizer to maintain its ADC leadership and to add innovative therapeutics to its pipeline across all stages of development.  Prior to joining Pfizer, Steve was at Seagen as VP of early-stage licensing.   Before Seagen, Steve spent 19 years at Merck.  Initially in the R&D organization before moving over to the WWBD organization.

Seminars:

Pharma Icebreaker: Activity in ADCs, Appetite for Radioligands & Alignment for Business 8:00 am

Discussing recent deal-making and current search and evaluation interests for context in the conference to follow Sharing insights into decision-making, due diligence, and necessary data packages to more confidently bring information to networking conversations Collectively hypothesizing future radioligand and ADC trends to present the buyer’s perspective on the potential of innovation in earlier developmentRead more

day: Day One - AM

Search & Evaluation Roundtables for Pharma Partnerships 10:15 am

Immerse yourself in the most valuable networking of the conference, and qualify yourself as a valuable prospect through face-to-face meetings with the pharma faculty. Rotate through pharma tables to understand how you align with search and evaluation interests, hear in-person feedback, and introduce your ADC innovations to multiple stakeholders. Select your tables ahead of time,…Read more

day: Day One - AM